Literature DB >> 22440826

Predicting longitudinal trajectory of bone mineral density in paediatric systemic lupus erythematosus patients.

Lily Siok Hoon Lim1, Susanne M Benseler, Pascal N Tyrrell, Elizabeth Harvey, Diane Herbert, Martin Charron, Earl D Silverman.   

Abstract

OBJECTIVES: (1) To identify the average lumbar spine (LS) bone mineral density (BMD) trajectory in paediatric systemic lupus erythematosus (pSLE) patients, and (2) to identify predictors of BMD trajectory.
METHODS: 68 consecutive newly diagnosed pSLE patients prospectively followed in our lupus cohort with three annual dual energy x-ray absorptiometry (DEXA) examinations were studied. Low LS BMD was defined as z-score ≤-2.0. Baseline and longitudinal clinical features including disease activity, treatment and bone physiology markers were collected. Hierarchical linear modelling was used to model trajectory of LS BMD and identify predictors.
RESULTS: Women constituted 84% of the cohort and median age at diagnosis was 13.1 years. The mean LS BMD z-scores decreased over time (-0.42 at first, -1.02 at second and -1.11 at third DEXA). Initially 9% of patients had a low BMD, which increased to 19% by 3 years after diagnosis. 35% of patients deteriorated in BMD category from the first to third DEXA. LS BMD (adjusted by height-for-age z-score) followed a general deteriorating trajectory of -0.06 z-score/year from diagnosis. Increased rate of deterioration of BMD trajectory was predicted by pubertal status at diagnosis, increased interval cumulative steroid exposure and decreased weight z-scores.
CONCLUSIONS: The LS BMD of pSLE patients followed a general deteriorating trend over time and could be predicted by a combination of pubertal status at diagnosis, interval cumulative doses of steroids and weight z-scores. Interval cumulative steroid dose represents an important target that clinicians may modify to ameliorate deteriorating BMD trajectory over time.

Entities:  

Mesh:

Year:  2012        PMID: 22440826     DOI: 10.1136/annrheumdis-2011-200805

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  An evidence-based perspective on warfarin and the growing bone: response to Sugiyama et al.

Authors:  M L Avila; E Pullenayegum; A Shammas; L R Brandão
Journal:  Osteoporos Int       Date:  2016-04-18       Impact factor: 4.507

2.  Evaluation of quality indicators and disease damage in childhood-onset systemic lupus erythematosus patients.

Authors:  Julia G Harris; Kristyn I Maletta; Evelyn M Kuhn; Judyann C Olson
Journal:  Clin Rheumatol       Date:  2016-12-24       Impact factor: 2.980

Review 3.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

4.  Incident Vertebral Fractures and Risk Factors in the First Three Years Following Glucocorticoid Initiation Among Pediatric Patients With Rheumatic Disorders.

Authors:  Claire M A LeBlanc; Jinhui Ma; Monica Taljaard; Johannes Roth; Rosie Scuccimarri; Paivi Miettunen; Bianca Lang; Adam M Huber; Kristin Houghton; Jacob L Jaremko; Josephine Ho; Nazih Shenouda; Mary Ann Matzinger; Brian Lentle; Robert Stein; Anne Marie Sbrocchi; Kiem Oen; Celia Rodd; Roman Jurencak; Elizabeth A Cummings; Robert Couch; David A Cabral; Stephanie Atkinson; Nathalie Alos; Frank Rauch; Kerry Siminoski; Leanne M Ward
Journal:  J Bone Miner Res       Date:  2015-05-26       Impact factor: 6.741

5.  Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study.

Authors:  M L Avila; E Pullenayegum; S Williams; A Shammas; J Stimec; E Sochett; K Marr; L R Brandão
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

6.  Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation.

Authors:  M Caetano; M T Terreri; T Ortiz; M Pinheiro; F Souza; R Sarni
Journal:  Clin Rheumatol       Date:  2015-07-31       Impact factor: 2.980

Review 7.  Childhood Lupus--Diagnosis and Management.

Authors:  Sujata Sawhney
Journal:  Indian J Pediatr       Date:  2016-01-05       Impact factor: 5.319

8.  Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids.

Authors:  Jennifer Harrington; Douglas Holmyard; Earl Silverman; Etienne Sochett; Marc Grynpas
Journal:  Pediatr Rheumatol Online J       Date:  2016-11-10       Impact factor: 3.054

9.  Effect of Vitamin D and Calcium Supplementation in Patients with Systemic Lupus Erythematosus.

Authors:  Abdullah G Al-Kushi; Firas S Azzeh; Eslam A Header; Naser A ElSawy; Haifa H Hijazi; Abdelelah S Jazar; Mazen M Ghaith; Mohammed A Alarjah
Journal:  Saudi J Med Med Sci       Date:  2018-08-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.